Margherita Patruno

Bari, 70124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications.

Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications.

Journal: International journal of molecular sciences

Published: May 16, 2026

Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer.

Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer.

Journal: United European gastroenterology journal

Published: January 13, 2026

The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations.

The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations.

Journal: Tumori

Published: August 09, 2025

BRCA cascade counselling and testing in Italy: current position and future directions.

BRCA cascade counselling and testing in Italy: current position and future directions.

Journal: BMC cancer

Published: March 24, 2025

Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience.

Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience.

Journal: Frontiers in medicine

Published: October 14, 2024

The molecular tumor board as a step in cancer patient management: a southern Italian experience.

The molecular tumor board as a step in cancer patient management: a southern Italian experience.

Journal: Frontiers in medicine

Published: May 14, 2024

Case report: Germline POT1 mutation in a patient with GIST and lung adenocarcinoma.

Case report: Germline POT1 mutation in a patient with GIST and lung adenocarcinoma.

Journal: Frontiers in oncology

Published: April 24, 2024

SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP).

SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP).

Journal: Virchows Archiv : an international journal of pathology

Published: June 27, 2023

Remote vs in-person BRCA1/2 non-carriers test disclosure: patients' choice during Covid-19 pandemic restriction.

Remote vs in-person BRCA1/2 non-carriers test disclosure: patients' choice during Covid-19 pandemic restriction.

Journal: Familial cancer

Published: March 01, 2022

Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing.

Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing.

Journal: Cancers

Published: August 10, 2021

Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.

Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.

Journal: International journal of molecular sciences

Published: June 12, 2021

Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers.

Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers.

Journal: Cancers

Published: May 19, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026